pharma · Asthma · Idiopathic pulmonary fibrosis (IPF)
Chiesi Farmaceutici S.p.A
Chiesi Farmaceutici S.p.A is a pharma organization headquartered in Parma, IT. Primary therapeutic focus areas include Asthma, Idiopathic pulmonary fibrosis (IPF), Mild to moderate asthma, Pulmonary fibrosis, Chronic obs
Company details
- Status
- Public
- HQ
- Via Paradigna, 131, Parma, Emilia-Romagna 43122, IT
- Employees
- 6,080
- Programs
- 20
- Drugs
- 38
- Patents
- 0
Quick answer
Chiesi Farmaceutici S.p.A is a pharma organization headquartered in Parma, IT. Primary therapeutic focus areas include Asthma, Idiopathic pulmonary fibrosis (IPF), Mild to moderate asthma, Pulmonary fibrosis, Chronic obstructive pulmonary disease (COPD). NovaPharmaNews links 20 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (10), phase 3 (6), phase 2 (3).
Company snapshot
Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, France and Col
- 20 active pipeline program(s) linked via ClinicalTrials.gov.
- 20 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Chiesi Farmaceutici S.p.A. Not investment advice.
Catalysts
Upcoming readouts, regulatory dates, and congress activity.
- approval
EC nod for Chiesi Lojuxta for pediatric HoFH: what it means for pharma
Recent coverage
Top assets
Lead pipeline drugs
- approved
- approved
- approved
- Marketed / approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for Chiesi Farmaceutici S.p.A.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitor landscape
Therapeutic-area overlap peers from registry and pipeline signals.
- Peer + 0 momentum
- Peer + 0 momentum
Recent activity
Latest pipeline, patent, and corporate events for Chiesi Farmaceutici S.p.A.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Chiesi Farmaceutici S.p.A?
-
Is Chiesi Farmaceutici S.p.A publicly traded?
-
What drugs does Chiesi Farmaceutici S.p.A develop or market?
-
What are the latest developments for Chiesi Farmaceutici S.p.A?
-
What therapeutic areas does Chiesi Farmaceutici S.p.A focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.